NDC 67184-0501-01 - Oxaliplatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67184-0501
- Requested NDC
- 67184-0501-01
- Package NDCs from labels
- 67184-0501-1, 67184-0501-01
- Manufacturer
- Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., (Hainan) Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd.
- Effective date
- 2021-10-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., (Hainan) Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. | 2021-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67184-0501-1 | Oxaliplatin | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 | |
| 67184-0501-1 | Oxaliplatin | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67184-0501 | OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [QILU PHARMACEUTICAL CO., LTD.] | 3 | Current NDC, Legacy NDC, 2 package rows | 20211020_e9e47f3c-9acc-44f5-b0bd-d26fe9d35d64.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxaliplatin | OXALIPLATIN | Gland Pharma Limited | a6f89dc3-a594-4b5b-8728-272e20c1ecb5 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Hospira, Inc. | e51a62ba-d163-4c57-835c-8c86cf097e40 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| oxaliplatin | OXALIPLATIN | Shandong New Time Pharmaceutical Co., Ltd. | 1ac38523-480b-4c0f-97a1-7dfa1432923c | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | NorthStar Rx LLC | f299b2d2-86ed-4fb8-822e-65455a0bb75a | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Northstar Rx LLC | 7dc8dfb1-dec8-43b3-b2ea-05eac054b2c6 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Camber Pharmaceuticals, Inc. | b0799e39-7b1e-430a-b159-062b39521001 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| oxaliplatin | OXALIPLATIN | Sagent Pharmaceuticals | 29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Mylan Institutional LLC | da0e8523-609a-4326-96b1-d7de78662d91 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | BluePoint Laboratories | b6083405-9b45-4d2c-e053-2995a90ad9ef | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Qilu Pharmaceutical Co., Ltd. | 33d4f4b4-bb4e-46af-9e89-df20154436d0 | 2024-11-14 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 11377169-7986-45b1-8298-6f0533efa3c3 | 2024-10-03 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | ee2e0da9-5ae7-405b-8dd1-635be72bc439 | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Apotex Corp. | ee5a5a1d-63f6-4d5a-901b-65be45ec6610 | 2024-08-04 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Apotex Corp. | bb180ec5-1f75-43c1-9f63-c0657af2ca5f | 2024-08-04 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Eugia US LLC | 1bb4febd-0ed4-48c9-ba2a-e22183a2143f | 2024-07-02 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 7e38318e-c569-4ad4-8f10-a235f30444d1 | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 873fa936-157a-4f85-bc70-5df31d71d122 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| oxaliplatin | OXALIPLATIN | Accord Healthcare Inc. | 4b805925-beb1-2bac-e054-00144ff88e88 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | FOSUN PHARMA USA INC. | fad0f147-6595-4412-87a7-2afca0192a96 | 2023-10-09 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
| Oxaliplatin | OXALIPLATIN | Sandoz Inc | 86f6c19d-30d1-42e3-8d46-5e3f45776e85 | 2023-07-25 | Boxed warning, Warnings, Adverse reactions | 04ZR38536J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.